ORBIMED ADVISORS LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC

Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT

Page:   < prev 1 ... 2 3 4 5 6 7 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.7213,967470,9672,159,4302.2 M to 2.2 M (-0.64 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.631,51851,05020,70322.2 K to 20.7 K (-6.83 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.63159,3825,360,0172,173,3972.3 M to 2.2 M (-6.83 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.771,11337,58622,22123.3 K to 22.2 K (-4.77 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.77116,8253,945,1802,332,7792.4 M to 2.3 M (-4.77 %)
Aug 12 2016LOXOLoxo Oncology, Inc ...ORBIMED ADVISORS LLCDirectorSellS26.96447,85712,074,2251,728,0002.2 M to 1.7 M (-20.58 %)
Aug 05 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.594,010122,66623,33427.3 K to 23.3 K (-14.67 %)
Aug 05 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.59420,99012,878,0842,449,6042.9 M to 2.4 M (-14.67 %)
Jul 26 2016RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS31.98343,60010,988,3283,356,4003.7 M to 3.4 M (-9.29 %)
Jul 26 2016RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS32.003,700,000118,400,0003,700,0007.4 M to 3.7 M (-50.00 %)
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00332,76600
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.001,071,99200
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.002,511,44100
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00627,86700
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorBuyP15.0033,334500,0104,801,6384.8 M to 4.8 M (+0.70 %)
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorBuyC0.00332,76604,768,3044.4 M to 4.8 M (+7.50 %)
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorBuyC0.001,071,99204,435,5383.4 M to 4.4 M (+31.87 %)
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorBuyC0.002,511,44103,363,546852.1 K to 3.4 M (+294.73 %)
Jul 25 2016BOLDAudentes Therapeut ...ORBIMED ADVISORS LLCDirectorBuyC0.00627,8670852,105224.2 K to 852.1 K (+280.00 %)
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00456,87000
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.004,35100
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.0077,69700
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.0073900
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00380,98600
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.003,62800
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorBuyP14.00544,8117,627,3541,825,4151.3 M to 1.8 M (+42.54 %)
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorBuyP14.005,18972,64617,38212.2 K to 17.4 K (+42.56 %)
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorBuyC0.001,166,88401,280,604113.7 K to 1.3 M (+1,026.10 %)
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorBuyC0.0011,111012,1931.1 K to 12.2 K (+1,026.89 %)
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00456,87000
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.004,35100
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.0077,69700
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.0073900
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00380,98600
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.003,62800
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorBuyP14.00544,8117,627,3541,825,4151.3 M to 1.8 M (+42.54 %)
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorBuyP14.005,18972,64617,38212.2 K to 17.4 K (+42.56 %)
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorBuyC0.001,166,88401,280,604113.7 K to 1.3 M (+1,026.10 %)
Jun 29 2016SELBSELECTA BIOSCIENCE ...ORBIMED ADVISORS LLCDirectorBuyC0.0011,111012,1931.1 K to 12.2 K (+1,026.89 %)
Jun 27 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.9990011,6915,379,3495.4 M to 5.4 M (+0.02 %)
Jun 27 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.921001,2925,378,4495.4 M to 5.4 M (0.00 %)
Jun 21 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.8726,083335,6885,378,3495.4 M to 5.4 M (+0.49 %)
Jun 21 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.4812,300153,5045,352,2665.3 M to 5.4 M (+0.23 %)
Jun 20 2016RPBIFRESPONSE BIOMEDICA ...ORBIMED ADVISORS LLCDirectorBuyP0.56331,225185,4862,149,9021.8 M to 2.1 M (+18.21 %)
Jun 20 2016RPBIFRESPONSE BIOMEDICA ...ORBIMED ADVISORS LLCDirectorBuyP0.565,2942,96534,29129 K to 34.3 K (+18.26 %)
Jun 20 2016RPBIFRESPONSE BIOMEDICA ...ORBIMED ADVISORS LLCDirectorBuyP0.56556,339311,5503,604,2663 M to 3.6 M (+18.25 %)
Jun 16 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.045,00060,2005,339,9665.3 M to 5.3 M (+0.09 %)
Jun 16 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP11.945,00059,7005,334,9665.3 M to 5.3 M (+0.09 %)
Jun 16 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.7110,000127,1005,329,9665.3 M to 5.3 M (+0.19 %)
Jun 13 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.9820,000259,6005,319,9665.3 M to 5.3 M (+0.38 %)
Jun 13 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.9530,000388,5005,299,9665.3 M to 5.3 M (+0.57 %)
May 25 2016ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorBuyP10.48518,4005,432,83229,753,40429.2 M to 29.8 M (+1.77 %)
May 25 2016ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorBuyP10.401,191,60012,392,64029,235,00428 M to 29.2 M (+4.25 %)
May 25 2016ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorBuyP10.042,40024,09628,043,40428 M to 28 M (+0.01 %)
May 24 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP13.094,71661,7325,269,9665.3 M to 5.3 M (+0.09 %)
May 20 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.75617785,265,2505.3 M to 5.3 M (0.00 %)
May 20 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.112,53930,7475,265,1895.3 M to 5.3 M (+0.05 %)
May 20 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP11.554,20048,5105,262,6505.3 M to 5.3 M (+0.08 %)
May 13 2016NTLAIntellia Therapeut ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00873,47500
May 13 2016NTLAIntellia Therapeut ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.002,857,14300
May 13 2016NTLAIntellia Therapeut ...ORBIMED ADVISORS LLCDirectorBuyP18.0058,5341,053,6122,662,1802.6 M to 2.7 M (+2.25 %)
May 13 2016NTLAIntellia Therapeut ...ORBIMED ADVISORS LLCDirectorBuyP18.00191,4663,446,3882,603,6462.4 M to 2.6 M (+7.94 %)
May 13 2016NTLAIntellia Therapeut ...ORBIMED ADVISORS LLCDirectorBuyC0.00564,78002,412,1801.8 M to 2.4 M (+30.57 %)
May 13 2016NTLAIntellia Therapeut ...ORBIMED ADVISORS LLCDirectorBuyC0.001,847,40001,847,4000 to 1.8 M
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00713,77600
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.003,994,67400
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP15.00550,0008,250,0005,258,4504.7 M to 5.3 M (+11.68 %)
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyC0.00713,77604,708,4504 M to 4.7 M (+17.87 %)
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyC0.003,994,67403,994,6740 to 4 M
Dec 23 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS27.5452,0581,433,6777,400,0007.5 M to 7.4 M (-0.70 %)
Dec 23 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS26.7847,9421,283,8877,452,0587.5 M to 7.5 M (-0.64 %)
Dec 23 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS27.0238,6301,043,7837,500,0007.5 M to 7.5 M (-0.51 %)
Dec 23 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS26.39111,3702,939,0547,538,6307.7 M to 7.5 M (-1.46 %)
Dec 23 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS28.3914,171402,3157,650,0007.7 M to 7.7 M (-0.18 %)
Dec 23 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS27.50235,8296,485,2987,664,1717.9 M to 7.7 M (-2.99 %)
Nov 30 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS29.2259017,2401,850,0941.9 M to 1.9 M (-0.03 %)
Nov 30 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS28.642,71677,7861,850,6841.9 M to 1.9 M (-0.15 %)
Nov 30 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS28.9729,000840,1301,853,4001.9 M to 1.9 M (-1.54 %)
Nov 30 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS28.9134,8001,006,0681,882,4001.9 M to 1.9 M (-1.82 %)
Nov 24 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS28.7536,1001,037,8751,917,2002 M to 1.9 M (-1.85 %)
Nov 24 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS28.4580,8002,298,7601,953,3002 M to 2 M (-3.97 %)
Nov 24 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS28.5983,9002,398,7012,034,1002.1 M to 2 M (-3.96 %)
Nov 19 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS28.60127,3003,640,7802,118,0002.2 M to 2.1 M (-5.67 %)
Nov 19 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS29.092005,8182,245,3002.2 M to 2.2 M (-0.01 %)
Nov 19 2015OTICOtonomy, Inc.ORBIMED ADVISORS LLCDirectorSellS28.8010,898313,8622,245,5002.3 M to 2.2 M (-0.48 %)
Oct 29 2015DMTXDimension Therapeu ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.005,692,87400
Oct 29 2015DMTXDimension Therapeu ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.009,500,00000
Oct 29 2015DMTXDimension Therapeu ...ORBIMED ADVISORS LLCDirectorBuyP13.00200,0002,600,0005,397,6985.2 M to 5.4 M (+3.85 %)
Oct 29 2015DMTXDimension Therapeu ...ORBIMED ADVISORS LLCDirectorBuyC0.001,947,61305,197,6983.3 M to 5.2 M (+59.92 %)
Oct 29 2015DMTXDimension Therapeu ...ORBIMED ADVISORS LLCDirectorBuyC0.003,250,08503,250,0850 to 3.3 M
Oct 22 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerBuyP12.92310,7004,014,2447,900,0007.6 M to 7.9 M (+4.09 %)
Oct 22 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerBuyP11.97189,3002,265,9217,589,3007.4 M to 7.6 M (+2.56 %)
Oct 13 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS5.982,78516,65417,10019.9 K to 17.1 K (-14.01 %)
Oct 13 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS5.98285,1061,704,9341,767,9022.1 M to 1.8 M (-13.89 %)
Oct 09 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS7.032,04114,34819,88521.9 K to 19.9 K (-9.31 %)
Oct 09 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS7.03210,6681,480,9962,053,0082.3 M to 2.1 M (-9.31 %)
Oct 09 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS7.243,83727,78021,92625.8 K to 21.9 K (-14.89 %)
Oct 09 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS7.24396,1632,868,2202,263,6762.7 M to 2.3 M (-14.89 %)
Oct 09 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS7.364543,34125,76326.2 K to 25.8 K (-1.73 %)
Oct 09 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS7.3653,446393,3632,659,8392.7 M to 2.7 M (-1.97 %)
Oct 06 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS7.805946026,21726.3 K to 26.2 K (-0.22 %)
Oct 06 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS7.806,94154,1402,713,2852.7 M to 2.7 M (-0.26 %)
Oct 06 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS8.191,1639,52526,27627.4 K to 26.3 K (-4.24 %)
Oct 06 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS8.19136,9371,121,5142,720,2262.9 M to 2.7 M (-4.79 %)
Oct 06 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.344034,16727,43927.8 K to 27.4 K (-1.45 %)
Oct 06 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.3447,497491,1192,857,1632.9 M to 2.9 M (-1.64 %)
Oct 01 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.344004,13627,84228.2 K to 27.8 K (-1.42 %)
Oct 01 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.3447,100487,0142,904,6603 M to 2.9 M (-1.60 %)
Oct 01 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.173693,75328,24228.6 K to 28.2 K (-1.29 %)
Oct 01 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.1743,471442,1002,951,7603 M to 3 M (-1.45 %)
Oct 01 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.088989728,61128.7 K to 28.6 K (-0.31 %)
Oct 01 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.0810,469105,5282,995,2313 M to 3 M (-0.35 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.308991728,70028.8 K to 28.7 K (-0.31 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.3010,513108,2843,005,7003 M to 3 M (-0.35 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS11.073113,44328,78929.1 K to 28.8 K (-1.07 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS11.0766,489736,0333,016,2133.1 M to 3 M (-2.16 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.078008,05629,10029.9 K to 29.1 K (-2.68 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.0764,400648,5083,082,7023.1 M to 3.1 M (-2.05 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS11.008,15289,6723,147,1023.2 M to 3.1 M (-0.26 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS11.001481,62829,90030 K to 29.9 K (-0.49 %)
Sep 28 2015SIENSientra, Inc.ORBIMED ADVISORS LLC10% OwnerSellS9.786593,155,2543.2 M to 3.2 M (0.00 %)
Jul 21 2015DNAIProNAi Therapeutic ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.001,725,79000
Jul 21 2015DNAIProNAi Therapeutic ...ORBIMED ADVISORS LLCDirectorBuyP17.00175,0002,975,0001,989,9491.8 M to 2 M (+9.64 %)
Jul 21 2015DNAIProNAi Therapeutic ...ORBIMED ADVISORS LLCDirectorBuyJ5.2289,159464,9641,814,9491.7 M to 1.8 M (+5.17 %)
Jul 21 2015DNAIProNAi Therapeutic ...ORBIMED ADVISORS LLCDirectorBuyC0.001,725,79001,725,7900 to 1.7 M
Jul 21 2015ICPTINTERCEPT PHARMACE ...ORBIMED ADVISORS LLCDirectorGrantA0.0028501,120,6091.1 M to 1.1 M (+0.03 %)
Jul 08 2015PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLCDirectorBuyP2.754,71712,97265,39860.7 K to 65.4 K (+7.77 %)
Jul 08 2015PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLCDirectorBuyP2.75495,2831,362,0287,194,2226.7 M to 7.2 M (+7.39 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseM7.652611,9970
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseM7.6527,346209,1970
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.002,67200
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.00280,53100
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.001,59900
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.00167,89800
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.0022,92300
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.002,406,44100
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorPayment of ExerciseF18.001111,99827,34427.5 K to 27.3 K (-0.40 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorBuyM0.00261027,45527.2 K to 27.5 K (+0.96 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorPayment of ExerciseF18.0011,623209,2142,870,5932.9 M to 2.9 M (-0.40 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorBuyM0.0027,34602,882,2162.9 M to 2.9 M (+0.96 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorBuyC0.0027,194027,1940 to 27.2 K
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorBuyC0.002,854,87002,854,8700 to 2.9 M
May 20 2015RLYPRelypsa IncORBIMED ADVISORS LLC10% OwnerSellS34.131,457,55149,746,2167,400,0008.9 M to 7.4 M (-16.46 %)
Mar 30 2015ICPTINTERCEPT PHARMACE ...ORBIMED ADVISORS LLCDirectorSellS294.829026,5341,120,3241.1 M to 1.1 M (-0.01 %)
Mar 30 2015ICPTINTERCEPT PHARMACE ...ORBIMED ADVISORS LLCDirectorSellS293.852,500734,6251,120,4141.1 M to 1.1 M (-0.22 %)
Mar 30 2015ICPTINTERCEPT PHARMACE ...ORBIMED ADVISORS LLCDirectorSellS292.136,0001,752,7801,122,9141.1 M to 1.1 M (-0.53 %)
Mar 30 2015ICPTINTERCEPT PHARMACE ...ORBIMED ADVISORS LLCDirectorSellS291.123,7001,077,1441,128,9141.1 M to 1.1 M (-0.33 %)
Mar 30 2015ICPTINTERCEPT PHARMACE ...ORBIMED ADVISORS LLCDirectorSellS290.0213,9744,052,7391,132,6141.1 M to 1.1 M (-1.22 %)
Mar 30 2015ICPTINTERCEPT PHARMACE ...ORBIMED ADVISORS LLCDirectorSellS289.0715,1314,373,9181,146,5881.2 M to 1.1 M (-1.30 %)
Mar 30 2015ICPTINTERCEPT PHARMACE ...ORBIMED ADVISORS LLCDirectorSellS288.1126,0287,498,9271,161,7191.2 M to 1.2 M (-2.19 %)

Page:   < prev 1 ... 2 3 4 5 6 7 next >

Contact us | Follow us on Twitter